CPIX: Cumberland Pharmaceuticals Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
32 institutions reported holding $16.00M of Cumberland Pharmaceuticals Inc on Form 13F (29 the quarter before). 8 opened a new position and 5 sold out. Shares held by institutions: -9%.
| Largest holders | Shares | Value |
|---|---|---|
| Ikarian Capital, LLC | 503,153 | $3.26M |
| RENAISSANCE TECHNOLOGIES LLC | 478,263 | $3.10M |
| VANGUARD CAPITAL MANAGEMENT LLC | 379,478 | $2.46M |
| DIMENSIONAL FUND ADVISORS LP | 233,305 | $1.51M |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,544 | $729K |
| GEODE CAPITAL MANAGEMENT, LLC | 108,413 | $703K |
| PERCEPTIVE ADVISORS LLC | 96,982 | $628K |
| CITADEL ADVISORS LLC | 73,391 | $476K |
| BlackRock, Inc. | 63,547 | $412K |
| Bank of New York Mellon Corp | 58,458 | $379K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.